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EZHIP constrains Polycomb Repressive Complex 2
activity in germ cells
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The Polycomb group of proteins is required for the proper orchestration of gene expression
due to its role in maintaining transcriptional silencing. It is composed of several chromatin
modifying complexes, including Polycomb Repressive Complex 2 (PRC2), which deposits
H3K27me2/3. Here, we report the identiﬁcation of a cofactor of PRC2, EZHIP (EZH1/2
Inhibitory Protein), expressed predominantly in the gonads. EZHIP limits the enzymatic
activity of PRC2 and lessens the interaction between the core complex and its accessory
subunits, but does not interfere with PRC2 recruitment to chromatin. Deletion of Ezhip in mice
leads to a global increase in H3K27me2/3 deposition both during spermatogenesis and at
late stages of oocyte maturation. This does not affect the initial number of follicles
but is associated with a reduction of follicles in aging. Our results suggest that mature
oocytes Ezhip−/− might not be fully functional and indicate that fertility is strongly impaired
in Ezhip−/− females. Altogether, our study uncovers EZHIP as a regulator of chromatin
landscape in gametes.
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Early in development, cells commit to speciﬁc lineages andacquire precise identities that require maintenancethroughout the lifespan of the organism. Polycomb group
proteins play an important role in this process by maintaining
transcriptional repression through the regulation of chromatin
structure1. In mammals, this machinery is composed of two main
complexes: Polycomb Repressive Complex 1 and 2 (PRC1 and 2).
The core PRC2 complex is composed of four subunits: the cat-
alytic subunit EZH1/2, SUZ12, EED, and RbAp46/481. PRC2
catalyzes the di- and tri-methylation of lysine 27 on histone H3
(H3K27me2/3), an enzymatic activity which is required for its
function. Indeed, the mutation of lysine 27 of histone H3
to arginine leads to loss of gene repression, and mutant ﬂies
display a phenotype similar to deletion of PRC2 components2.
H3K27me3 is generally enriched around the promoter of tran-
scriptionally silent genes and contributes to the recruitment of
PRC11. H3K27me2 is widely distributed, covering 50–70% of
histones, and its role is less deﬁned but may be to prevent
aberrant enhancer activation3.
The question of how PRC2 is targeted to chromatin and how
its enzymatic activity is controlled has received ongoing atten-
tion4. Cumulative evidence suggests that PRC2 may not be
actively recruited to chromatin and that, instead its activity, is
promoted by the recognition of its own mark H3K27me3, ubi-
quitination of lysine 119 of H2A, GC-richness, or by condensed
chromatin4. Conversely, some histone modiﬁcations negatively
inﬂuence PRC2 function, particularly those associated with
active transcription, such as H3K4me3 and H3K36me34. PRC2
binding to chromatin may also be inhibited by DNA methyla-
tion5, although other reports suggest that PRC2 is compatible
with DNA methylation6.
A number of accessory subunits have now been shown to
inﬂuence PRC2 function4. Recent comprehensive proteomic
analyses suggest that they might form around two main
PRC2 subtypes, PRC2.1 and PRC2.27. The subunit SUZ12 plays a
central role by orchestrating the cofactor interactions8. PRC2.1
includes one of the three Polycomb-like proteins (PHF1, MTF2 or
PHF19) together with the recently identiﬁed PRC2 partners
EPOP and PALI19,10. The three Polycomb-like proteins harbor
one Tudor domain and two PHD ﬁnger domains each4. Their
Tudor domain is able to recognize H3K36me3 decorated genes,
which could be important for PRC2 association with transcribed
targets4. The function of EPOP remains ambiguous since, in vitro,
it stimulates PRC2 catalytic activity while, in vivo, it limits PRC2
binding, likely through interaction with Elongin BC11. In con-
trast, PALI1 is required for H3K27me3 deposition both in vitro
and in vivo10. The other complex, PRC2.2, includes JARID2 and
AEBP2 subunits in equal stoichiometry12,13. Both are able to
stimulate PRC2 catalytic activity in vitro with JARID2 being also
able to bind nucleosomes14. JARID2 also appears to be necessary
for PRC2 targeting at its loci, possibly through its DNA-binding
domain or as a result of its methylation by PRC24. AEBP2
binds to DNA in vitro, but appears to negatively modulate
PRC2 in vivo15,16. Of note, AEBP2 was reported to stimulate
PRC2 through a mechanism independent of PRC2 allosteric
activation17,18. While we now have a good picture of the acces-
sory subunits interacting with PRC2, their precise roles are only
partially understood. This might be due to compensatory
mechanisms, such that interfering both with PRC2.1 and PRC2.2
is required to inhibit PRC2 recruitment19 as observed upon loss
of SUZ1220.
The regulation of chromatin structure in germ cells is pivotal,
as these cells are the bridge between generations and therefore
potential vector of epigenetic information. In particular,
H3K27me3 has been shown to be involved in parental imprint-
ing21–23. Yet, in contrast to the extensive characterization of
PRC2 in models, such as mouse embryonic stem cells (ESC),
much less is known about the regulation of its enzymatic activity
in germ cells. Deletion of PRC2 core components during sper-
matogenesis results in the progressive loss of germ cells, indi-
cating that its activity is required for this process24,25. At later
stages of spermatogenesis, when round spermatids differentiate
into mature sperm, histones are progressively replaced by pro-
tamines. A variable fraction of the genome retains a nucleosomal
structure (1% in mice, 10–15% in human), with histones carrying
posttranslational modiﬁcations, including H3K27me326. During
oogenesis, histones are maintained and H3K27me3 is detected
throughout this process27–29. However, H3K27me3 displays a
peculiar pattern of enrichment in the growing oocyte, showing
broad enrichment in intergenic regions and gene deserts
(reviewed in refs. 30,31). Genetic interference with PRC2 function
in growing oocytes does not prevent their maturation, but has
been linked to a postnatal overgrowth phenotype in the progeny32
possibly through the control of imprinting23.
Here, we report the identiﬁcation of a tissue-speciﬁc cofactor of
PRC2, EZHIP. In human and mouse, we show that this cofactor
is expressed primarily in gonads and that it limits PRC2-mediated
H3K27me3 deposition. Inactivation of this cofactor in mice
results in excessive deposition of this mark both during sper-
matogenesis and oogenesis. We further provide evidences that
mutant oocytes with this altered epigenetic content are not fully
functional, and that mouse female fertility is impaired.
Results
Identiﬁcation of a cofactor of PRC2 in the gonad. PRC2
recruitment and enzymatic activity is controlled by a set of
cofactors interacting in a partially mutually exclusive manner
with the core subunit SUZ12, but little is known about its reg-
ulation in germ cells. To tackle this question, we ﬁrst focused on
testes (more abundant material than ovaries), and took advantage
of knock-in mouse models expressing an N-terminal Flag-tagged
version of either EZH1 or EZH2 from their respective endogen-
ous locus (this study and33). We veriﬁed the expression of the
tagged-EZH1 by western blot on mouse testis nuclear extract,
and were able to detect the presence of a slowly migrating
polypeptide, which is speciﬁcally pulled down by Flag-
Immunoprecipitation (Flag-IP) (Supplementary Fig. 1A). We
then isolated nuclei from adult mouse testes (WT control, EZH2-
Flag or EZH1-Flag), performed Flag-IP, and subjected the sam-
ples to mass spectrometry. The results of three independent IPs
are represented as volcano plots (Fig. 1a; Supplementary Fig. 1B).
As expected, both EZH1 and EZH2 proteins interact with the
other PRC2 core components and with known accessory sub-
units: AEBP2, JARID2, PHF1, and MTF2 (Fig. 1a; Supplementary
Fig. 1B). Interestingly, our experiments also reveal the existence
of an additional partner, the uncharacterized protein AU022751
(ENSMUST00000117544; NM_001166433.1), which we retrieved
in both EZH1 and EZH2 pulldowns. We referred to this cofactor
as “EZHIP” for EZH1/2 inhibitory protein. Of note, this protein
was previously identiﬁed in PRC2 interactomes of mouse
embryonic stem cells, but its function was not further
investigated13,34,35. In order to conﬁrm this interaction, we
overexpressed Flag-tagged versions of the mouse and human
homologs in HeLa-S3 cells (Supplementary Fig. 1C), and per-
formed IP followed by mass spectrometry. These reverse IPs
conﬁrmed the interaction between PRC2 and EZHIP (Fig. 1b;
Supplementary Fig. 1D). Additional putative partners were
identiﬁed in both IPs, but with the exception of USP7, they were
not common to both homologs. We therefore did not
pursue their study further. Importantly, these reverse IPs also
indicate that EZHIP interacts with both PRC2 complex subtypes.
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Fig. 1 EZHIP interacts with PRC2 in gonads. a Volcano plot of EZH2 interactome from EZH2-Flag mice testis IP compared with WT. Core complex subunits
are in red, in green the cofactors and in blue EZHIP, n= 3. b Volcano plot representation of EZHIP interactome after Flag-IP from HeLa-S3 overexpressing
EZHIP compare with WT. Same color codes as in (a), n= 3. c Schematic representation of EZHIP protein sequence from Mus Musculus (upper part) and
Homo Sapiens (middle part). Serine-rich region is colored in beige, and conserved amino acid stretch in green. The conserved sequence stretch is displayed
as well as protein residues conservation between the two sequences in green (Sequence Homology determined using Genious software). d Ezhip and Ezh2
mRNA relative abundance normalized to Tbp in various mice tissues (mean, n= 2). e EZHIP and EZH2 IHC staining on human adult seminiferous tubules
sections. Representative result, n≥ 5. Scale bars, 50 μm. f EZHIP and EZH2 IHC staining on human adult ovaries sections, black arrows indicate the
follicles. Representative result, n≥ 5. Scale bars, 30 μm
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EZHIP is located on the X chromosome. In most species, it is a
monoexonic gene—that may indicate that it was generated by
retroposition—but in the mouse, splicing also creates a shorter
isoform. Using phylogenetic analysis by maximum likelihood
(PAML), we observed that EZHIP homologs are present across
Eutheria, but we did not identify any homologs outside of this
clade based on either sequence conservation or on synteny.
EZHIP genes have rapidly evolved both at the nucleotide and
amino acid levels, the rodent homologs being particularly distant
from the rest (Fig. 1c; Supplementary Fig. 1E). This contrasts with
the other PRC2 components, such as EZH2, which are highly
conserved across mammals (Supplementary Fig. 1E). No known
protein domain was predicted for EZHIP, and the only
distinguishing feature is a serine-rich region (Fig. 1c in green),
including a short amino acid stretch that is fully conserved in all
orthologs identiﬁed (Fig. 1c in purple). To characterize Ezhip
expression, we performed RT-qPCR on various tissues (3-month-
old females and males). Ezhip mRNA expression was particularly
high in ovaries; it was also expressed in testes, and much less in
other tissues (Fig. 1d). Of note, Ezhip transcript level appears at
least tenfold higher than any PRC2 core components or cofactors
in oocytes (Supplementary Fig. 1F). Ezhip’s pattern of expression
is distinct from that of Ezh2, which is expressed tissue wide, with
the strongest expression observed in the spleen. Analysis of public
gene expression data sets from fetal gonads36 indicates Ezhip is
preferentially expressed in E13.5 primordial germ cells (PGCs)
compared with somatic cells, correlating with germ cell
markers, such as Piwil2 or Prdm14 (Supplementary Fig. 1G).
Interestingly, Ezhip belongs to a set of genes referred to as
“germline-reprogramming-responsive” that become active fol-
lowing PGC DNA demethylation37, as they are associated with
strong CpG island promoters. Similarly, in humans EZHIP is
highly transcribed in male and female PGCs from week 5 until
week 9 of pregnancy, while almost absent in ESCs and somatic
cells (Supplementary Fig. 1H)38. We conﬁrmed this observation
at the protein level by performing immunohistochemistry on
sections of testes and ovaries of human origin. hEZHIP protein
was detected in male germ cells inside the seminiferous tubules,
especially in spermatogonia and round spermatids (Fig. 1e). In
ovaries, EZHIP antibody stained primordial follicles and oocytes
(red arrows), but not the external follicle cells in contrast to EZH2
antibody, which stained both zones (Fig. 1f). To summarize,
EZHIP is a genuine cofactor of PRC2 in placental mammals. It is
a fast-evolving protein with no known protein domain, it is
expressed primarily in PGCs during development and remains
present in the adult gonad.
EZHIP is a negative regulator of PRC2 activity. To study the
molecular role of EZHIP, we sought a model cell line that would
express this factor endogenously. The EZHIP transcript is
undetectable from most cell lines, with the exception of U2OS, an
osteosarcoma-derived cell line (Supplementary Fig. 2A). We used
genome editing to generate U2OS clonal cells that were knockout
for EZHIP or for EED as a control for PRC2 inactivation (U2OS
EZHIP−/− and U2OS EED−/−, respectively). Both cell lines
were viable, and had not overt phenotype. Western blot showed
that deletion of EED destabilized the other PRC2 core compo-
nents, such as EZH2, while inactivation of EZHIP had no dis-
cernible effect on the accumulation of these proteins (Fig. 2a). We
then assessed H3K27 methylation and observed a robust increase
in H3K27me2/3 upon EZHIP deletion, while H3K27me1 was
stable and H3K27ac slightly reduced (Fig. 2b). Interestingly,
H3K27me3 level was very low in U2OS compared with extract
prepared from HEK-293T cells, which do not express EZHIP
(Supplementary Fig. 2B). To conﬁrm that EZHIP deletion was
directly responsible for the increased H3K27me3 in U2OS, we
stably restored its expression using either full-length (FL) or
deletion mutants (Fig. 2c) as veriﬁed by western blot (WB) and
RT-q-PCR (Supplementary Fig. 2C). Upon re-expression of FL
and mutant EZHIP, H3K27me3 returned to basal levels (Fig. 2c,
d) with the notable exception of mutant M5 that lacks the con-
served amino acids stretch (Fig. 2c). Given that such deletion
abolishes EZHIP interaction with PRC2 in co-IP (mutant 6 vs.
mutant 7; Supplementary Fig. 2D), it stands to reason that EZHIP
likely regulates H3K27me3 deposition through direct interference
with PRC2 activity.
To determine whether these alterations of PRC2 activity
translate into aberrant gene expression, we analyzed the
transcriptome of U2OS in the different genetic contexts described
above by RNA-seq (Fig. 2d). Only a few genes were differentially
expressed in U2OS EED−/− as compared with WT (FDR < 0.05),
whereas ~500 genes were differentially expressed in EZHIP−/−
vs. WT. The majority of which were downregulated, as expected
considering the global gain of H3K27me3 repressive mark. Of
note, gene ontology analysis of the genes downregulated upon
EZHIP knockout did not reveal any robust categories (Supple-
mentary Fig. 2E). Altogether, these results reveal that EZHIP
inhibits the activity of PRC2 thus altering gene expression proﬁle.
Interplay between H3K27me2 & me3 upon expression of
EZHIP. Having shown the effects of EZHIP on PRC2 activity at
the global level, we then investigated how this affects the chro-
matin landscape locally. First, we analyzed H3K27me3 genomic
distribution in the absence of EZHIP by chromatin immuno-
precipitation followed by sequencing (ChIP-seq). We used the
U2OS EED−/−, in which H3K27me3 is not detectable as a
negative control and compared it to the U2OS wild-type WT and
EZHIP−/−. Replicates were well correlated and the U2OS WT
and U2OS EED−/− clustered together, away from the U2OS
EZHIP−/− (Supplementary Fig. 3A). This agrees with our earlier
observation that H3K27me3 is very low in U2OS, as in the EED
knockout (Supplementary Fig. 2B). In contrast, there was a
genome-wide increase in H3K27me3 deposition upon deletion of
EZHIP (Fig. 3a), as demonstrated by the large number of peaks
detected in this context (Supplementary Fig. 3B).
To further characterize the role of EZHIP, we analyzed the
genome-wide distribution of H3K27me2, H3K27ac, and H2Aub in
U2OS WT vs. U2OS EZHIP−/− by “CUT&RUN”39. Replicates
clustered together as expected (Supplementary Fig. 3C), and the
correlation matrix revealed that H3K27me2 in the U2OS WT
clusters with H3K27me3 in the EZHIP−/− condition, suggesting
that EZHIP limits the conversion of H3K27me2 into H3K27me3.
This global correlation is conﬁrmed when zooming on a
speciﬁc region as illustrated by genome-browser screen shot (e.g.
DRGX, Fig. 3b). At this locus, H2Aub and H3K27ac displayed
only modest variations, and their enrichment appeared not
particularly affected by the deletion of EZHIP. Focusing
speciﬁcally on peaks that gain H3K27me3 upon deletion of
EZHIP (Fig. 3c), we noticed a general decrease of H3K27me2 with
a slight depletion around the peaks of H3K27me3 when
comparing U2OS WT to U2OS EZHIP−/− (Fig. 3d). Of note,
what happen for H3K27me2 at the regions gaining H3K27me3 in
the U2OS EZHIP−/− does not reﬂect the genome-wide trend.
Indeed, overall, we observe an increase of H3K27me2 illustrated
by the increase number of peaks in the absence of EZHIP
(Supplementary Fig. 3D). H3K27ac, which is known to antic-
orrelate with H3K27me2/3 enrichment, was low and appeared to
slightly decrease in the absence of EZHIP. Regarding H2Aub, the
enrichment of the mark is only modestly increased by the
deletion of EZHIP (Fig. 3d). If we focus on the TSS of genes either
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upregulated or downregulated in the absence of EZHIP, we
observed again a robust increase of H3K27me3 and an increase of
H3K27ac for the downregulated genes and upregulated, respec-
tively, whereas the other histone marks are only slightly affected
(Fig. 3e). We conclude that EZHIP limits the activity of PRC2
favoring the deposition of H3K27me2 at regions normally
enriched for H3K27me3. Of note, this altered chromatin
landscape is reminiscent of what has been described upon
expression of H3K27M mutant oncogenic histone40.
EZHIP impairs PRC2 activity, but not its binding to chro-
matin. Considering the inhibitory action of EZHIP on PRC2, we
next sought to explore the underlying mechanisms. First, we
hypothesized that EZHIP could limit PRC2 binding to chromatin.
To test this hypothesis, we performed CUT&RUN against SUZ12
to monitor PRC2 recruitment to chromatin, comparing U2OS
WT, U2OS EED−/−, and U2OS EZHIP−/−. Focusing again on
DRGX, we observed that SUZ12 enrichment is lost in the absence
of EED, whereas SUZ12 is enriched both in U2OS WT and U2OS
EZHIP−/− (Fig. 4a). This result held true when we analyzed
all the peaks that gain H3K27me3 in the absence of EZHIP
(Supplementary Fig. 4A). Overall, we observed a slight increase of
SUZ12 enrichment in particular at the regions ﬂanking the peaks.
Since our attempts to immunoprecipitate EZHIP were unsuc-
cessful, we used immunoﬂuorescence (IF) to evaluate its coloca-
lization with EED and H3K27me2. The speciﬁcity of EZHIP
antibody by IF is demonstrated by the lack of signal in U2OS
EZHIP−/− (Supplementary Fig. 4B). In U2OS WT, EZHIP
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staining appeared as a diffuse nuclear staining which overlaps
partially with the signal detected for EED (Fig. 4b). Of note,
EZHIP staining tends to be excluded from the bright dots
detected with the anti-H3K27me2 antibody. Since EZHIP mod-
estly impacts PRC2 binding to chromatin but H3K27me3
deposition is impaired, this suggested that EZHIP may instead
interfere with PRC2 enzymatic activity. To test this hypothesis,
we ﬁrst evaluated whether a titration of puriﬁed EZHIP (Sup-
plementary Fig. 4C) inhibited the enzymatic activity of the
recombinant PRC2 core complex in a histone methyltransferase
assay. However, even at molar excess, EZHIP did not impact the
enzymatic activity of PRC2 (Supplementary Fig. 4D). We then
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TSS of genes either upregulated or downregulated upon known out of EZHIP as deﬁned in Fig. 2d
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reasoned that EZHIP might regulate PRC2 activity only in the
presence of its cofactors. To test this hypothesis, we puriﬁed the
core PRC2 and its cofactors from U2OS and U2OS EZHIP−/−
cells that stably overexpress a Flag-tagged version of EZH2
(Supplementary Fig. 4D). EZH2 was immunoprecipitated, and
further puriﬁed through an ion-exchange column before mon-
itoring its activity on native histones. While we observed very low
methyltransferase activity toward H3 with PRC2 puriﬁed from
WT cells, the complex puriﬁed from U2OS EZHIP−/− was much
more active (Fig. 4c left vs. central panel). Furthermore, in contrast
to our observation, with the recombinant core PRC2 complex, the
titration of EZHIP on PRC2 puriﬁed from U2OS EZHIP−/−
inhibited PRC2 enzymatic activity (Fig. 4c right panel). These
results suggest that EZHIP might regulate PRC2 by mitigating its
interaction with its cofactors. To test this hypothesis, we analyzed
PRC2 interactome by mass spectrometry, depending on EZHIP
expression status. Overall, PRC2 displayed the same composition
(Supplementary Fig. 4F); however, the stoichiometry of the
cofactors appeared substantially different in the absence of
EZHIP (label-free quantiﬁcation based on iBAQ). Namely, several
cofactors—AEBP2, JARID2, and PALI1—were present at a higher
stoichiometry in the IPs from EZHIP−/− cells. (Fig. 4d). We
conﬁrmed this result by co-IP/WB investigating the interaction of
AEBP2 and JARID2 with EZH2 in IPs performed with nuclear
extracts prepared from U2OS wild-type or EZHIP−/− cells
(Fig. 4e). Our results suggest that EZHIP does not prevent PRC2
c
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binding to chromatin, but limits the stimulatory action of
cofactors, such as AEBP2 and JARID2 on its enzymatic activity.
Ezhip−/− males are fertile despite H3K27me3 increase. To
study the role of EZHIP in a more physiological environment, we
generated a knockout mouse model in which a CRISPR-Cas9-
induced deletion of 1.5 Kb removes most of the gene body
(Supplementary Fig. 5A). Accordingly, Ezhip mRNA and protein
were absent from testis and from ovaries (Supplementary Fig.
5B–D), two organs where Ezhip is preferentially expressed. Of
note, expression of the genes ﬂanking Ezhip (Nudt10 and Nudt11)
were unaffected by the deletion (Supplementary Fig. 5B, D). Ezhip
mice (−/− or −/Y) did not show any overt developmental defect,
with adults appearing undistinguishable from the wild-type.
We ﬁrst investigated the expression of Ezhip during
spermatogenesis in the different subpopulations of germ cells
sorted from adult mice based on staining for α6-integrin, the
tyrosine kinase receptor c-Kit, and DNA content, as previously
described41,42. Ezhip was mostly expressed in spermatogonia
(α6-integrin positive, Supplementary Fig. 5E). Its expression
was very low in spermatocytes I and II, consistent with the
global transcriptional inactivation of the X chromosome at
these stages43, in contrast to Ezh2 expression, which increases
at the ﬁnal stages of differentiation (4n, 2n and n; Supplemen-
tary Fig. 5E).
We then tested whether deletion of Ezhip could enhance
H3K27me3 deposition during spermatogenesis, as it does in
U2OS cells. For this, we probed nuclear extracts from whole testes
of adult mice by western blot. As shown in Fig. 5a, amounts of
H3K27me2 and me3 increased by about twofold in the absence of
EZHIP, whereas other histone marks remain unchanged.
Consistent with our previous observations, this effect was not
due to a direct effect on the protein accumulation of PRC2 core
components (Fig. 5a bottom panel).
To identify the cellular origin of this H3K27me2/me3
upregulation, we performed immunoﬂuorescence on testis
sections. Triangle-shaped somatic Sertoli cells—identiﬁed by
the presence of two satellite chromocenters in their nuclei after
DAPI staining—were strongly positive for H3K27me3 in both
WT and KO condition (Fig. 5b, yellow star;44). In contrast,
germ cells—identiﬁed by expression of the germ cell marker
TRA98—displayed much stronger H3K27me3 signal in Ezhip
−/Y mice compared with WT littermates (Fig. 5b, yellow
arrows). This suggest that EZHIP does not regulate H3K27me3
deposition in somatic cells of the testis. Indeed, in Dnmt3l
mutant testes that are germ cell free45, no consistent variation
in H3K27me3 patterns was observed in presence or absence of
EZHIP (Supplementary Fig. 5F).
To evaluate the functional consequences of aberrant
H3K27me3 deposition, we proﬁled gene expression of α6+c-
kit- undifferentiated spermatogonia in WT and Ezhip −/Y mice.
Gene expression was moderately affected by the absence of
EZHIP: about 125 genes differentially expressed (FDR < 0.05,
Fig. 5c), the majority of which were downregulated. To
determine the impact on spermatogenesis, we analyzed the
different germ cell subpopulations from WT and Ezhip −/Y
testes by cell cytometry. The relative sizes of these subpopula-
tions were unaffected (Fig. 5d; Supplementary Fig. 5F), in
agreement with the normal testis-to-body weight ratio and
normal fertility of Ezhip −/Y males (Supplementary Fig. 5G).
Finally, we evaluated sperm quality through computer-assisted
images analysis of spermatozoa. Spermatozoa motility was not
substantially affected, although spermatozoa from Ezhip −/Y
males showed slightly less progressive motility, and were a bit
more static (Fig. 5e; Supplementary Table 1). While most
histones are replaced by protamine in mature spermatozoa, a
small minority carrying various histone modiﬁcations including
H3K27me3 is retained46–48. To determine whether Ezhip
deletion impacts this residual H3K27me3, we quantiﬁed this
mark in the epidydimal sperm. Western blot of sperm extracts
isolated from Ezhip −/Y mice displayed higher H3K27me3 levels
compared with sperm originating from WT animals (Fig. 5h).
Whether this upregulation has any functional consequences
remains to be investigated, nonetheless, these results conﬁrm the
inhibitory activity of EZHIP on H3K27me3 deposition in male
germ cells. Interestingly, they reveal that an excess of H3K27me3
is compatible with spermatogenesis and male fertility.
EZHIP controls H3K27me3 deposition in postnatal oocytes. In
female, classical assembly of chromatin is conserved throughout
oogenesis. While the genome-wide deposition of H3K27me3 in
PGCs remains to be investigated, H3K27me3 was reported to be
progressively restricted during oogenesis to “non-canonical”
locations, such as intergenic regions and gene deserts28. To assess
whether EZHIP could play a role in the regulation of H3K27me3
during different stages of female germline, we ﬁrst investigated its
expression in available data sets in speciﬁed germ cells and in
postnatal stages of oocyte development. Ezhip is very lowly
expressed in migrating PGCs (E9.5), as they entered the genital
ridges (E10.5), and as they undergo epigenetic reprogramming
(E12.5)27. Its expression increases and mirror the one of Ezh2
only in later germ cells ((GCs) E14.5–E15.5) (Fig. 6a, left panel,
data from49)). Interestingly, Ezhip expression is much higher in
postnatal oocytes at all stages of growth (Fig. 6a, left and right
panels, data from49,]50). Ezhip expression drops sharply post
fertilization (Fig. 6b). Considering this pattern, we evaluated
H3K27me3 levels in postnatal gametes. We performed pre-
pubertal female follicles (P17) immunoﬂuorescence against
H3K27me3 in wild-type and Ezhip−/− conditions. H3K27me3
levels were slightly higher in Ezhip−/− primordial follicles
compared to WT (Fig. 6c, right panel for quantiﬁcation). As this
difference became more pronounced in secondary follicles (Fig.
6c), we went on investigating H3K27me3 levels at the fully grown
oocyte (FGO) stage in adult females. We ﬁrst harvested germinal
vesicle (GV) oocytes from 3-month-old female siblings and
stained for H3K27me3 and DAPI; H3K27me3 levels appeared to
be around twice more abundant in Ezhip−/− oocytes, both in the
less condensed chromatin state with no rim surrounding the
nucleolus (NSN) and in the fully condensed chromatin state with
a DNA-dense rim surrounding the nucleolus (SN) (Fig. 6d;
Supplementary Fig. 6A). Of note, this effect was speciﬁc to
H3K27me3 modiﬁcations, as H3K4me3 levels were not lower in
NSN oocytes (Supplementary Fig. 6B). Finally, a strong increase
in H3K27me3 deposition was also observed in mature MII
oocytes from 4-month-old Ezhip−/− females (Fig. 5e). We
conclude that EZHIP restrains the deposition of H3K27me3
during oocyte maturation.
Oocyte defects upon deletion of Ezhip. To evaluate the con-
sequences of this global gain in H3K27me3 on gene expression,
we ﬁrst analyzed the transcriptome of a pool of MII oocytes
harvested after superovulation of pre-pubertal females (4-weeks
old). RNA-seq analysis revealed a very similar transcriptome for
the mutant oocytes compared with WT (Fig. 7a). We next
investigated whether transcriptomic alterations could appear with
aging, as well as if there could be some variability in the tran-
scriptome of individuals oocytes. To this end, we performed
single-oocyte-RNA-seq (9 WT and 10 Ezhip−/− 4-month-old
oocytes). We ﬁrst ran the comparison between wild-type to
mutant in aged oocytes by pooling the single-cell results to mirror
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our analysis with younger females. We observed that in aged
oocytes, the number of signiﬁcantly differentially expressed genes
remains limited, although the comparative expression pattern
appears more dispersed (Fig. 7b). This prompted us to determine
whether there could be some heterogeneity in terms of gene
expression among the oocytes as observed for global H3K27me3
level (Fig. 6d, e). To address this question, we performed principal
component analysis of single oocytes. This revealed that while
most of the oocytes (regardless of Ezhip expression) clustered
together, two Ezhip−/− oocytes, originating from distinct
mice, were clear outliers (Fig. 7c). One of the top genes
differentially expressed comparing the outliers and the rest of the
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Ezhip−/− oocytes was Mos (Fig. 7d). Mos has been shown to be
required for MAP kinase activation during oocyte maturation,
and its deletion impairs microtubules and chromatin organization
during the MI to MII transition51. Next, we checked the chro-
mosome metaphase plate in MII oocytes, and found that Ezhip
mutant mice displayed a slight increase in the number of oocytes
with lagging chromosomes compared with control (6-week-old;
Fig. 7e). Our single oocytes RNAseq and staining of individual
oocytes revealed some heterogeneity in oocyte maternal pool as
well as in general competence for fertilization. Altogether, our
results support a general role for EZHIP in oocyte ﬁtness by
regulating H3K27me3 deposition.
Impaired fertility of Ezhip knockout females. We next investi-
gate whether EZHIP could be involved in the control of follicle
maturation. We did not observe any signiﬁcant differences in the
number of primordial, primary, and secondary/antral follicles of
pre-pubertal females (P17) regardless of Ezhip expression status,
indicating that the initial oocyte pool is apparently intact (Fig. 8a,
top panels). In contrast, sections from older females (16 weeks)
showed a global reduction in the follicle number in the absence of
EZHIP (Fig. 8a, bottom panels), although the low number of
mature follicles (primary and secondary/antral) at this age was
insufﬁcient to reach statistical signiﬁcance. Collectively, these data
suggest a progressive, age related, exhaustion of primordial follicle
reserve, from which growing follicles develop. Incidentally,
ovaries from Ezhip−/− females appeared smaller, with a weight
that was reduced by about 30% compared with wild-type and
heterozygous counterparts (Fig. 8b).
In line with these results, we observed that Ezhip−/− female
mice give rise to fewer progeny. We therefore monitored their
fertility by comparing the size and number of litters of WT vs.
mutant females (Fig. 8c). Six-week-old WT and Ezhip−/−
females were mated with a reliably fertile male in the same cage,
and monitored daily for 20 weeks (Fig. 8c). All litters were
genotyped to assign them to the correct mother; the numbers of
mice at birth and at 3 weeks of age (time of genotyping) were
similar. However, the total number of pups obtained from
Ezhip−/− mothers considerably decreased each month, as the
females aged (Fig. 8c). This reﬂected both a reduction in litter
number (WT females gave birth to around three litters over a
period of 20 weeks while mutant females gave birth to only one
litter) and litter size (WT females gave birth to an average of 8
pups/litter while the Ezhip−/− average litter size was around 3/4
pups/litter) (Fig. 8d). This result is unlikely to result from
developmental defects of the reproductive track since uterine
horns appeared normal in adult Ezhip−/− females (Supplemen-
tary Fig. 7).
We conclude from these experiments that absence of Ezhip in
oocytes leads to alterations of the epigenetic landscape and is
associated to strong reduction in female fertility. Whether the
impairment in oocyte pool and its ﬁtness might impair
subsequent development of the embryo around and after
fertilization remains to be determined.
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Discussion
Gametogenesis entails signiﬁcant reprogramming of the epigen-
ome. While histone replacement in spermatogenesis and the
progressive loss of DNA methylation during germ cell speciﬁca-
tion are well documented27,52, less is known about the regulation
of histone posttranslational modiﬁcations during this process.
Here, we focus on the Polycomb complex PRC2 to investigate this
question. We identify an additional PRC2 interacting protein
speciﬁc to the gonad and showed that it inhibits PRC2 enzymatic
activity. Inactivation of this factor leads to a global increase of
H3K27me3 during both spermatogenesis and oogenesis. Altera-
tion of the epigenetic content of oocytes leads to a severely
compromised fertility.
The PRC2 complex exists in several ﬂavors, depending on
which enzymatic subunits it is formed around (EZH1 or EZH2)
and depending on which set of cofactors it interacts with7. It is
known that EZH1 and EZH2 exert redundant functions in
spermatogenesis25, consistent with this redundancy both subunits
have a similar interactome in adult mouse testis. Among it,
EZHIP contrasts with most of the cofactors identiﬁed to date: (i)
its expression seems mostly restricted to germ cells, (ii) homologs
have only been found in Eutherians and it is a fast-evolving
protein, (iii) it is a robust inhibitor of PRC2 enzymatic activity,
and (iv) it pulls down the entire PRC2 interactome. These last two
characteristics are likely linked: it is expected that effective inhi-
bition of PRC2 requires all ﬂavors of PRC2 to be regulated. The
poor sequence conservation of EZHIP sequence and its rather
disordered structure prediction are more surprising considering
that PRC2 and its cofactors are, in contrast, very well conserved.
This suggests that the speciﬁcity of action of EZHIP on PRC2
could be primarily conferred by the conserved stretch of 13
amino acids. Such a mechanism involving a short-linear motif in
direct contact with binding partners (including chromatin
modiﬁers) is a common strategy for parasites such as toxoplasma
to manipulate the host cellular machineries53. It will be particu-
larly interesting to perform structural analyses in order to pre-
cisely determine how this interaction occurs, how it interferes
with the binding of AEBP2, JARID2, or PALI1 to PRC2, and how
this impairs the enzymatic activity of PRC2 without impacting its
recruitment to chromatin.
Another interrogation raised by this study is the advantage of
expressing an inhibitor of PRC2 to limit H3K27me3 deposition in
the gonads rather than downregulating the enzyme itself. We
speculate that an inhibitor enables a tighter control over the
timing of the reduction in PRC2 activity. Consistent with this
possibility, Ezhip was recently identiﬁed among a set of genes that
is expressed in PGCs, in response to the developmental DNA
demethylation of the germline genome37. Of note, its localization
on the X chromosome, explains that it remains expressed in
oocytes while it is silenced in spermatocytes due to meiotic sex
chromosome inactivation. The link between the wave of DNA
demethylation and expression of this inhibitor of PRC2 raises the
question of whether both processes are functionally related (i.e.
whether PRC2 has to be inhibited when DNA methylation is
lowered). It will be interesting to map H3K27me3 deposition in
Ezhip−/− oocytes in order to determine whether it maintains
broad enrichment in intergenic regions or at gene deserts30 and
also, whether it could impact on the reestablishment of DNA
methylation during oocyte growth.
Recent reports have shown that H3K27me3 on the maternal
genome is important for the regulation of allele-speciﬁc gene
expression23, and therefore that disrupting PRC2 activity in
oocyte through the deletion of Eed impairs, post-fertilization, the
allelic expression of a subset of genes54. Conversely, it is tempting
to speculate that PRC2 activity might be limited by EZHIP in
order to prevent it from invading genomic regions and thus
potentially promoting excessive imprinting. Our results also
suggest that excessive H3K27me3 levels resulting from Ezhip
deletion in testicular germ cells are partially retained in mature
spermatozoa. Although it does not seem to impact on the ferti-
lizing properties of the spermatozoa, it will be interesting to
determine whether embryos derived from oocytes fertilized with
Ezhip−/− sperm develop normally. If they do, it would be con-
sistent with the report that paternally inherited H3K27me3 is
rapidly erased in the zygote, and carries limited intergenerational
potential28.
Finally, both gain and loss of PRC2 function are a recurrent
observation in cancers. While we were completing this study,
another publication reported the identiﬁcation of EZHIP
(CXORF67) as an inhibitor of PRC2 in two cancer cell lines
(U2OS and Daoy Cells55). This demonstrates another means by
which cancer cell lines might curtail PRC2 function. Further
studies are required to know whether EZHIP upregulation might
be a recurrent event in cancers and act as a driver of tumor
progression. Of note, EZHIP has also been involved in gene
translocations occurring in endometrial stromal sarcoma, a rare
malignant tumor of the uterus56. Previous reports revealed fre-
quent fusion between the transcriptional repressor JAZF1 and the
PRC2 core component SUZ12, and it was proposed that this
fusion could alter PRC2 function57. Interestingly, PRC2-cofactors
can also be involved in fusions with transcriptional regulators, as
it is the case for PHF1 with JAZF1, MEAF6, or EPC158. Our study
extends this observation by showing that the fusion between
EZHIP and the nuclear protein malignant brain tumor domain-
containing 1 (MBTD1) could result in aberrant PRC2 targeting58.
It will be important to investigate how these fusions contribute to
tumor progression and whether the inhibition of PRC2 could
constitute a therapeutic strategy.
Methods
Cloning. mEzhip cDNA clone was obtained from ORIGENE (Ref. MG214772).
hEZHIP cDNA clone was ampliﬁed from HEK-293T genomic DNA. hEZHIP
mutant 1 (a.a. 1–420), EZHIP mutant 2 (a.a.100–503), EZHIP mutant 3 (a.a.
200–503), EZHIP mutant 4 (a.a. 300–503), EZHIP mutant 6 (a.a. 1–450), and
EZHIP mutant 7 (a.a. 1–395) were generated by PCR and cloned into pMSCV-
Hygromycin retroviral vector and/or pCMV4-HA. EZHIP mutant 5, depleted of
13AA conserved stretch (a.a.1–503, Δ 394–417) was generated by amplifying the
two ﬂanking parts by PCR with overlapping overhangs59. EZHIP and Ezhip cDNA
were ampliﬁed by PCR and subcloned into pREV retroviral vector (gift form S. Ait-
Si-Ali), downstream a 2 × -Flag-2 × -HA sequence and upstream IRES followed by
CD25 cDNA.
Cell lines. U2OS (ATCC) and HEK-293T (Invitrogen) cell lines were grown
according to the manufacturer’s instructions. Cell lines were tested for the absence
of mycoplasma every month. All transfections were performed using PEI (poly-
ethylenimine) and 150 mM NaCl at 6:1 ratio to DNA. U2OS EED−/− cell line was
generated by co‐transfecting (i) gRNA targeting EED, (ii) hCas9, and (iii) a tar-
geting cassette bearing Hygromycin resistance ﬂanked by 1 kb sequences homo-
logous to EED locus. Hygromycin B clone selection was performed at 0.2 mg/ml.
U2OS EZHIP−/− cell line was generated by the same strategy with a targeting
construct conferring puromycin resistance (selection was performed at 0,5 mg/ml).
Selected U2OS EZHIP−/− clone has also undergone NHJ reparation with around
20 bp deletion at the N-terminal part of the sequence. Rescue experiments on
U2OS EZHIP−/− cell line was performed by infection with retroviral vectors
expressing EZHIP FL or mutants stably selected with Hygromycin B 0.2 mg/ml.
HeLa-S3 cells (gift form S. Ait-Si-Ali) were grown in the DMEM. pREV
retroviruses are produced by transfecting of 293T-Phoenix cell line (gift form S.
Ait-Si-Ali) and collecting supernatant after 60 h. HeLa-S3 cells were infected by
incubation with viral supernatants for 3 h at 37 °C. Infected cells were then selected
by FACS sorting using an anti-CD25-FITC-conjugated antibody and following
manufacturer instructions (BD Biosciences 553866). Expression of the recombinant
proteins were assessed by WB analysis of nuclear extracts.
Retroviral production. Production of pMSCV-Hygromycin retroviral vectors was
performed in 293T cells. Transduction was performed by incubating the cells with
viral particles mixed with Polybrene (ﬁnal concentration, 8 μg/ml) for 3 h at 37 °C
and subsequently selected with Hygromycin B was added at 0.2 μg/ml.
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Nuclear extract and Flag-IP. For nuclear extract preparation, cells were incubated
with buffer A (10 mM HEPES pH 7.9, 2.5 mM MgCl2, 0.25M sucrose, 0.1% NP-40,
0.5 mM DTT, 1 mM PSMF) for 10 min on ice, centrifuged at 7000 xg for 10 min,
resuspended in buffer B (25 mM HEPES pH 7.9, 1.5 mM MgCl2, 700 mM NaCl,
0.5 mM DTT, 0.1 mM EDTA, 20% glycerol), sonicated and centrifuged at 21,000 xg
during 15 min. For immunoprecipitation 1 mg of nuclear extract diluted in BC0 to
a ﬁnal salt concentration of 250 mM was incubated with 125 μl of Flag M2 Beads
(SIGMA-ALDRICH-A4596), washed three times with BC250 (50 mM Tris pH 7.9,
250 mM KCl, 2 mM EDTA, 10% Glycerol, and protease inhibitors), and eluted with
0.2 M glycine pH 2.6.
Protein gel and immunoblotting. Nuclear extracts were fractionated by SDS-
PAGE and transferred to the nitrocellulose by semi-dry transfer (Bio-Rad). The
membrane was blocked with 5% nonfat milk in PBS-0.1% Tween-20 for 60 min,
the membrane was washed once with the same buffer and incubated with anti-
bodies at 4 °C overnight. Membranes were washed three times for 5 min and
incubated with either a 1:5000 (mouse)/1:10000 (rabbit) dilution of horseradish
peroxidase-conjugated secondary antibodies or with ﬂuorophore-conjugated
1:5000 dilution of Starbright700 (Biorad) for 2 h at room temperature. Blots were
washed three times and developed with SuperSignal™ West Pico PLUS Chemilu-
minescent Substrate (Thermo Fisher). Immunoblots incubated with ﬂuorescent
secondaries antibody were visualized using the BIORAD ChemiDoc MP. Raw data
for western blot are provided in Supplementary Figs. 8–14.
Mass spectrometry analysis. Afﬁnity puriﬁcations and liquid chromatography
coupled to tandem mass spectrometry (LC–MS) analysis was performed with the
same protocol for either testis nuclear extracts, HelaS3 nuclear extracts or U2OS60.
In brief, nuclear extracts were subjected to a single step Flag-immunoprecipitation
(IP) in triplicate (ipFLAG). Control IPs were performed on extracts not expressing
the Flag-tagged protein61. Nuclear extracts from the Flag-tagged cell line were also
incubated with beads lacking Flag antibody. Thus, nine pulldowns were performed
in total, three speciﬁc pulldowns and six control pulldowns. Precipitated proteins
were subjected to on-bead trypsin (Promega) digestion. Peptides were extracted
and analyzed by nanoLC-MS/MS using an EASY nLC 1000 system (Thermo Sci-
entiﬁc) coupled to an Orbitrap Fusion mass spectrometer or Q Exactive mass
spectrometer (Thermo Fisher Scientiﬁc). Samples were desalted and concentrated
on c18 STAGE tips. After elution the peptides were separated on a C18 column
(75 μm i.d. x 30 cm, packed with C18 Reprosil -Pur, 1.9 μm, 100 Å; Dr. Maish)
equilibrated in solvent A (water containing 0.1% HCOOH). Bound peptides for the
fusion were eluted using a linear gradient of 140 min (from 9 to 32% (v/v)) of
solvent B (80% MeCN, 0.1% HCOOH), and then is increased to 95% of solvent B,
at 250 nl min ﬂow rate and an oven temperature of 40 °C. Samples measured on the
QE were eluted using a 120 min (from 9 to 32% (v/v)) of solvent B (80% MeCN,
0.1% HCOOH), and is increased to 95% of solvent B, at 250 nl min ﬂow rate and an
oven temperature of 40 °C. Fusion samples were acquired in Survey MS scans in
the Orbitrap on the 400–1500 m/z range with the resolution set to a value of
120,000 and a 4 × 105 ion count target. Tandem MS was performed by isolation at
1.6 Th with the quadrupole, HCD fragmentation with normalized collision energy
of 35, and rapid scan MS analysis in the ion trap. The MS2 ion count target was set
to 104, and the max injection time was 35 ms. Only those precursors with charge
state 2–7 were sampled for MS2. The dynamic exclusion duration was set to 60 s
with a 5 ppm tolerance around the selected precursor and its isotopes. The
instrument was run in top speed mode with 3 s cycles. Samples measured on the
QE were collected in a top10 data-dependent acquisition mode with 70.000 reso-
lution for the full scan in the mass range of 300–1650 m/z and a 3 × 106 ion count
target. Fragment ions were acquired by stepped energy of 25. Target was set to 1 ×
105 with an injection time of 120 ms. Only peptides with a charge state of 2–7 were
fragmented.
The data processing was done with the MaxQuant software. HelaS3 RAW data
were analyzed with MaxQuant version 1.5.0.1 and searched against the uniprot-
Human database downloaded from Uniprot (July 2014). Mouse testis RAW data
were analyzed with Maxquant version 1.5.0.0 and search against the mouse
database downloaded from Uniprot (July 2014). U2OS RAW data were analyzed
with MaxQuant version 1.6.1.0 and was searched against the human database
downloaded from Uniprot (June 2017). For all the searches, standard settings were
used. Trypsin was set as the used enzyme, and methionine oxidation and the N-
terminal acetylation were considered as variable modiﬁcations, and cysteine
carbamidomethyl was set as a ﬁxed modiﬁcation. Mass tolerance for the precursor
was set to 20 ppm. The fragment tolerance for the Fusion was 0.5 Da and for the
QE 20 ppm. In all the searches the FDR was set to 0.01.
Identiﬁed proteins were ﬁltered for reverse hits and common contaminants.
LFQ intensities were log2 transformed, and missing values were semi-random
imputed from a normal distribution (width= 0.3 and shift= 1.8) in Perseus. Then
proteins were ﬁltered to be detected in all replicates of at least one triplicate
experiment. A t test in perseus was used to determine the signiﬁcant outliers.
Recombinant proteins puriﬁcation and baculoviruses. Recombinant EZH2,
SUZ12, EED, RBAP48, JARID2 1–530, EZHIP full-length, and mutant proteins
were produced in SF-9 insect cells after infection with the corresponding
baculoviruses. Lysates were resuspended in BC300, sonicated and clariﬁed by
centrifugation before incubation with either Flag-beads (M2-beads, SIGMA_AL-
DRICH 4596) and eluted with Flag peptide, or Streptactin–sepharose suspension
(IBA, 2-1201-010) and eluted with 2.5 mM Desthiobiotin in BC300. hEZHIP and
mutant form baculoviruses were produced accordingly to Bac-to-Bac Baculovirus
Expression Systems (Invitrogen) after cDNA cloning into pFASTbac vectors.
Recombinant EZHIP proteins were further puriﬁed on size exclusion chromato-
graphy (S200).
KMT assay. KMT assay with recombinant PRC2 and EZHIP proteins were per-
formed with 200 ng of PRC2 alone or in presence of EZHIP, 1 µg of substrates,
4 mM DTT in methylation reaction buffer (50 mM Tris-HCl pH 8.5, 2.5 mM
MgCl2), 3H-SAM, and incubated at 30 °C for 30 min. For KMT assay with PRC2-
Flag puriﬁed from U2OS WT and EZHIP−/−, nuclear extracts were ﬁrst fractio-
nated on High Trap Q (GE Healthcare) prior to Flag-IP. Nucleosomal substrate for
the assay was assembled from 5S 12 repeats DNA62 and puriﬁed HeLa cell histone
octamers by salt dialysis through a linear gradient (2.2 M NaCl to 0.4 M NaCl)
followed by dialysis against TE solution.
Antibodies. Antibodies against EZH1/2, SUZ12, JARID2, and EED were pre-
viously characterized33,63. RBAP48 mouse mAb (GWB-C12FDE) was purchased
from GenWay Biotech; H3 mAb (39163) and H3K27me2 mAb (61435) were
purchased from Active Motif. Polyclonal rabbit one against H3 from Cell Signaling
Technology (9715); H3K9me2 (ab1220) and H3K27Ac (ab 4729) were purchased
from Abcam; H3K27me1 mouse mAb C0321 from Active Motif; H3K27me3
Rabbit mAb C36B11 (9733), H3K4me3 Rabbit mAb C42D8 (9751), Rabbit mAb
D7C6X (14129), Rabbit mAb H2AK119ub (8240 S) and mouse mAb10E2 HDAC1
(5356 S) from Ozyme (Cell Signaling Technology). hEZHIP (HPA006128) and
mAb Flag-M2 (F1804) were purchased from SIGMA; Anti-Germ cell-speciﬁc
Rabbit Polyclonal DPP3A/Stella (19878) and TRA98 (Ab82527) Rat monoclonal
one from Abcam. For Immunoﬂuorescence, EED was detected with the M26
antibody. Antibody against mEZHIP was raised against the two following synthetic
peptides: CAESSRAESDQSSPAG (corresponding to a.a. 91–106) and CAQ-
SAGRNLRPRPRSS (corresponding to a.a. 192–206). Anti-mouse β-TUBULIN was
purchased from Invitrogen 32–2600.
Primary antibodies were diluted 1:3000 for WB analysis and 1:250 for
Immunostaining.
Mouse lines. Mice were hosted in pathogen-free animal facility. All experi-
mentation was approved by the Institut Curie Animal Care and Use Committee
(project APAFIS #14570-2018040917413626-v1), and adhered to European and
national regulation for the protection of vertebrate animals used for experimental
and other scientiﬁc purposes (directives 86/609 and 2010/63). EZH2-Flag and
EZH1-Flag33 knock-in mice were generated by homologous recombination at the
Institute Clinique de la Souris (ICS). For tissue and collection, mice were eutha-
nized by cervical dislocation. The Ezhip mouse line was derived by CRISPR/Cas9
engineering of a 1.5-kb deletion spanning the AU022751 locus (Supplementary Fig.
4) in embryos at the one-cell stage, according to published protocols64. Of the 13
pups generated, eight carried at least one modiﬁed allele. Two founders (N0)
carrying the expected 1.5-kb deletion were selected. The absence of in silico-
predicted off-target mutations was veriﬁed by Sanger sequencing, the two founders
were bred with C57B6N mice. Two additional backcrosses were performed to
segregate out undesired genetic events, following a systematic breeding scheme of
crossing Ezhip heterozygous females with C57B6N males to promote transmission
of the deletion. Cohorts of female and male mice were then mated to study
complete knockout progeny.
Histological sections and immunostainings. For histological sections, testis and
ovary from either human patients from Curie Institute Pathology Platform or mice
were dissected, ﬁxed for 6 h in 4% paraformaldehyde (Sigma), and washed with
70% ethanol according to pathology platform standard protocols. Organs were
parafﬁn-embedded, sectioned (8 μm), and stained with hematoxylin using standard
protocols.
For cryosections, testes and ovaries from adult mice (6-month-old males; 2.5
and 5-month-old females) were dissected, ﬁxed overnight in 4% paraformaldehyde
at 4 °C, washed in PBS, followed by two consecutive overnight incubations in 15
and 30% sucrose at 4 °C, respectively. Testes were embedded in O.C.T. compound
(Tissue-Tek), 8–10 μm-thick sections were cut and spotted onto Superfrost Plus
slides (Thermo Fisher Scientiﬁc).
For immunoﬂuorescence detection, testis slides were brought to room
temperature, blocked and permeabilized for 1 h (10% donkey serum, 3% BSA and
0.2% Triton). For IF on cell lines, slides were ﬁxed with PFA (paraformaldehyde
4%) for 5 min, permeabilized for 5 min (Triton 0.5% in PBS), and blocked for
30 min in 20% goat serum in PBS. Slides were incubated with primary antibodies at
4 °C overnight, followed by three PBS-0.1% Tween-20 washes and 2 h incubation
with Alexa Fluor-conjugated secondary antibodies. Slides are washed three times
again in PBS-0.1% Tween-20 and incubated with DAPI 1 µg/µl for 5 min. After a
quick wash in PBS, slides were mounted with Mounting Media (Life technologies).
Images were acquired with a Inverted Laser Scanning Confocal LSM700 UV Zeiss
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microscope with a ×40 objective and Z-step in the case of Z-stack scanning. For
immunoﬂuorescence on p17 female mice ovary section, antigen retrieval is ﬁrst
performed in 10 mM sodium citrate, 0.05% Tween-20, pH= 6 at 80 °C for 20 min,
before proceeding with following steps as indicated above. Images of the section are
acquired with a Leica SP8 Confocal microscope, with open pinhole and ×10
objective. For IF on cell lines, images were acquired either with a Leica DM6000B
or a Zeiss LSM 800.
Immunohistochemistry on parafﬁn-embedded human samples. Slides were
baked 1 h at 65 °C, before deparafﬁnization and hydration in xylene and graded
ethanol to distilled water. Endogenous peroxidase was blocked for 5 min in 1.5%
H2O2 in methanol, antigen retrieval step was performed by boiling slides for 20
min in “Antigen unmasking solution” (Vector Laboratories) and cooling down 1 h
at RT. Slides are quickly washed in PBS for 5 min, blocked in PBS-2% BSA-5% FBS
1 h at RT, and incubated overnight at 4 °C in a humid chamber with primary
antibody. After washing three times for 5 min in PBS, slides were incubated with
biotinylated secondary antibody (Vector Laboratories) for 30 min. Slides were
washed in PBS three times for 5 min, before incubating with the ABC substrate for
30 min at RT. After washing again with PBS, DAB was prepared according to the
manufacturer instruction (Vector Laboratories), and the staining reaction mon-
itored from 1 to 5 min. Slides were stained with H/E following standard methods,
dehydration steps from 90% ethanol solution to xylene is performed, and slides
were mounted in VectaMount permanent Mounting Media (Vector Laboratories).
Analysis of mice testis cell populations. Testicular single-cell suspensions were
prepared from 2–3-months-old from WT and Ezhip−/− mice. The albuginea was
removed, and the seminiferous tubules were dissociated using enzymatic digestion
by collagenase type I at 100 U/ml for 25 min at 32 °C in Hanks’ balanced salt
solution (HBSS) supplemented with 20 mM HEPES pH 7.2, 1.2 mM MgSO4, 1.3
mM CaCl2, 6.6 mM sodium pyruvate, 0.05% lactate. Next, a ﬁltration step was
performed with a 40 -μm nylon mesh to discard the interstitial cells. After HBSS
wash, tubules were further incubated in Cell Dissociation Buffer (Invitrogen) for
25 min at 32 °C. The resulting whole-cell suspension was successively ﬁltered
through a 40 -μm nylon mesh and through a 20 -μm nylon mesh to remove cell
clumps. After an HBSS wash, the cell pellet was resuspended in incubation buffer
(same as previously plus glutamine and 1% fetal calf serum). Cell concentrations
were estimated using Tryptan Blue staining (> 95% viable cells).
Hoechst staining (5 μg/ml) of the cell suspensions was performed accordingly to
previous report41,65. Cells were labeled with anti-β2m-FITC (Santa Cruz), anti-α-6
integrin-PE (GoH3), and anti-CD117 (c-KIT)-APC (2B8) antibodies (BD
Pharmingen). For puriﬁcation of undifferentiated spermatogonia, MACS (Miltenyi
Biotech), α-6 integrin positive fraction of cells was obtained using anti-α-6
integrin-PE (GoH3) and anti-PE microbeads according to the manufacturer’s
protocol. This fraction was labeled with anti-β2m-FITC (Santa Cruz) and anti-
CD117 (c-KIT)-APC (2B8), and then sorted. Propidium iodide (Sigma) was added
before cell sorting to exclude dead cells. Analyses and cell sorting were respectively
performed on LSR II and ARIA ﬂow cytometers (Becton Dickinson).
Mouse sperm quality test. Adult male mice were euthanized by dislocation, and
cauda epididymis was collected post-mortem after carefully removing fat pad.
Epididymis was opened and sperm released in IVF media (Vitrolife). 1:100 sperm
dilution was loaded on Ivos (Hamilton Thorne machine) and sperm parameters
were evaluated by Remote Capture software.
Mouse fertility evaluation. Six-week-old WT and Ezhip−/− females (N= 13 each
genotype) were crossed and monitored for 20 weeks. One WT female and one Ezhip
−/− female mouse were housed with an adult breeder male tested previously. Cages
were monitored daily and pup numbers and litters were constantly registered. Adult
females were euthanized at the end of the study and gonad morphology analyzed.
Organ phenotypic analysis. Adult males and females starting from 3/4-months
old have been euthanized, ovaries/testis collected, and individually weighted. The
whole-organ weight has been considered for comparison among the three geno-
types for females and testis weight ratio for males.
Follicle counting. Sections were prepared as described above:
(1) For p17 mice, follicles were counted from at least 2 sections each organ/
genotype (N= 4 each genotype). Primary antibody against DPPA3 (Stella) was
used to stain germ cells and DAPI staining to stain nuclei. Different types of
follicles were classiﬁed by surrounding follicular cells shape.
(2) For 16-week-old mice, follicles number were counted from at least
13 sections each organ/genotype (N= 3 each genotype). In all, 5 µM parafﬁn
sections have been stained with hematoxylin and eosin. Follicle classiﬁcation
was based on Pedersen and Peters66. Ovaries were serially sectioned, and one
every three sections was counted. Follicles were counted from 13 sections and
represented as average number per slide per genotype. Measurements were
done using a Leica Epiﬂuorescence microscope.
Nuclei isolation and extraction from tissues. Mice tissues are rapidly extracted in
PBS and dounce homogenized (cut into small pieces with scissors, then 6x up-
down with loose and 4x with tight pestle) adding sucrose solution 2.2 (sucrose 2.2
M, HEPES 1M pH 7.6, KCl 3 M, EDTA 0.5 M, spermine 0.1 M, spermidine 1M,
and protease inhibitors). Homogenized is mixed and added onto sucrose solution
2.05 (sucrose 2.05 M, HEPES 1M pH 7.6, KCl 3M, EDTA 0.5 M, spermine 0.1 M,
spermidine 1 M, and complete set of protease inhibitors added last minute) in
ultracentrifuge Beckemann tubes. Spin 45 min, 24 k at 1 °C in a SW28 rotor. Nuclei
pellets were resuspended in an equal volume of nuclear lysis buffer (HEPES 1M,
pH 7.6, KCl 3 M, EDTA 0.5M, glycerol 87%, spermine 0.1 M, spermidine 1 M, NaF
0.5 M, Na2VO4 0.5 M, ZnSO4 50 mM, and complete set of protease inhibitors).
Samples were snap-frozen in liquid nitrogen.
GV and MII oocytes isolation from female mice. Germinal vesicle (GV) stage
oocytes were obtained from 12-week-old females. The ovaries were removed,
passed in pre-warmed PBS, and transferred to the M2 medium supplemented with
100 µg/mL of dibutyryl cyclic AMP (dbcAMP; Sigma-Aldrich) at 38 °C. The
ovarian follicles were punctured with a 21-gauge needle, and GV oocytes (fully
grown oocytes exhibiting a centrally located GV) have been washed ﬁve times
through M2 droplets in order to ensure that dbcAMP is removed. Zona pellucida
has been removed by three passages in tyroide acid solution, followed by three
washes in the M2 medium. GV oocytes were further washed in PBS and processed
for Immunostaining as described below.
Six-week (chromosome abnormality measurement) or 16-week-old mice were
superovulated by intraperitoneal injection using 5 IU pregnant mare’s serum
gonadotropin (PMSG) and 5 IU of human chorionic gonadotropin (hCG) 48 h
later. MII oocytes were collected from ovaries of 12-week-old mice in the M2
medium. Cumulus–oocyte complexes were collected from infundibulum at 14 h
after hCG treatment, and recovered in the M2 medium. Cumulus cells were
dispersed by hyaluronidase (300 IU/mL) for 5 min in the M2 medium, and oocytes
were washed twice with M2 medium and left in PBS for 5 min. No zona pellucida
removal treatment has been performed.
Immunoﬂuorescent staining of GV and MII oocytes. GV or MII Oocytes were
ﬁxed for 20 min in PBS containing 2.5% paraformaldehyde (PFA) at room tem-
perature, and washed with 1% BSA-PBS three times. The cells were permeabilized
by incubating in 1% BSA-PBS containing 0.5% Triton X-100 for 30 min at RT.
After washing with 1% BSA-PBS three times, oocytes were incubated with primary
antibodies in 1% BSA-PBS containing 0.1% Triton X-100 O/N at 4 °C. They were
subsequently washed once with 1% BSA-PBS-0.1% Triton X-100 and incubated for
1 h in the dark with Alexa Fluor 488-conjugated IgG secondary antibody (dilution
1:250) in the same buffer. DNA was stained twice for 15 min with 4,6-diamidimo-
2-phenylindole (DAPI) prior to a 15 min wash in PBS-0,1% Triton X-100. Cells are
passed through increasing percentages of glycerol solution for increasing times
(2.5% for 5 min–5% for 5 min-10% for 10 min– 20% for 5 min–50% for 15
min–DTG for 15 min) were then mounted on glass slides with ProLong Gold
mounting medium (Life Technologies) for sequential Z-stack imaging. Fluores-
cence was detected using an Inverted Laser Scanning Confocal LSM700 UV Zeiss
microscope with a 63x objective and Z-stack scanning. More than eight oocytes
were examined for each condition unless otherwise speciﬁed.
RT-qPCR from mouse tissues. The total RNA was isolated using the Rneasy Mini
Kit (Qiagen). cDNA was synthetized using High Capacity cDNA RT kit (4368814-
Applied Biosystems), and quantitative PCR was performed with technical triplicate
using SYBR green reagent (Roche) on a ViiA7 equipment (Applied Biosystems). At
least three biological independent experiments were performed for each assay.
Primers sequences are provided in Supplementary Table 2.
RNA extraction from mature MII oocytes. Oocytes were incubated in the M2
containing tyroide acid’s solution for 2–3 min to remove their ZP (zona pellucida).
ZP-free oocytes were carefully washed several times with M2, and were pooled
prior to lysis in XB buffer from Arcturus PicoPure RNA isolation Kit (Applied
Biosystems). We then added the spike-in control External RNA Control Con-
sortium (ERCC) molecules (Invitrogen). Normalization was performed using
ERCC spike in at 1:1,000,000. The puriﬁed total RNA concentration was measured
using Agilent High Sensitivity RNA ScreenTape on Agilent 2200 TapeStation.
First-strand cDNA (from total RNA) was synthesized according to the SMART-
Seq™ v4 Ultra™ Low Input RNA Kit protocol (Clontech Laboratories). The PCR-
ampliﬁed cDNA was puriﬁed using SPRI beads (Beckmann Coulter).
RNA sequencing from mature MII oocytes. For sequencing, 75 bp paired-end
reads were generated using the Illumina MiSeq. Raw reads were trimmed for
adapters with cutadapt (1.12) using the Trim Galore! (0.4.4) wrapper (default
settings) and subsequently mapped to the complete mouse rRNA sequence with
Bowtie2 (2.2.9). Reads that did not map to rRNA were then mapped with STAR
(2.5.3a) to the full reference genome (UCSC build GRCm38/mm10) (including the
RNA spike-in control sequence ERCC92, Thermo Fisher cat. no. 4456740)
using the following parameters: --outSAMtype BAM SortedByCoordinate --run-
Mode alignReads --outFilterType BySJout --outFilterMultimapNmax 20
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--alignSJoverhangMin 8 --alignSJDBoverhangMin 1 --outFilterMismatchNmax
999 --outFilterMismatchNoverLmax 0.04 --alignIntronMin 20 --alignIntronMax
1000000 --alignMatesGapMax 1000000 --outSAMprimaryFlag OneBestScore
--outMultimapperOrder Random --outSAMattributes All. Gene counts were gen-
erated using STAR --quant_mode (uniquely mapped, properly paired reads that
overlap the exon boundaries of each gene).
For differential expression analysis, genes were ﬁltered to include those with
CPM > 0.2 in at least two samples, and ﬁltered counts were transformed to log2-
CPM and normalized with the TMM method. A linear model was ﬁt to the
normalized data, and empirical Bayes statistics were computed. Differentially
expressed genes for the KO vs. WT were identiﬁed from the linear ﬁt after
adjusting for multiple testing and ﬁltered to include those with FDR < 0.05 and
absolute log2 fold change > 1.
RNA-seq in spermatogonial stem cells. Kit- spermatogonial population was
isolated by FACS as speciﬁed above from adult mice testis WT and Ezhip −/Y
(pool of three different mice per experiment for each genotype). Sorted cells were
resuspended directly in XB lysis buffer from Arcturus PicoPure RNA isolation Kit
(Applied Biosystems). The puriﬁed total RNA was stored in nuclease-free water,
and RNA concentration was measured using Agilent High Sensitivity RNA
ScreenTape. cDNA synthesis and library preparation were performed using
SMARTer Stranded Total RNA-Seq Kit-Pico Input Mammalian. 100 bp paired-end
reads were generated using the HiSeq 2500 platform. Raw reads were trimmed for
adapters with cutadapt (1.12) using the Trim Galore! (0.4.4) wrapper (default
settings) and subsequently mapped to the complete mouse rRNA sequence with
Bowtie2 (2.2.9). Unmapped reads were then mapped with STAR (2.5.3a) to the full
reference genome (GRCm38/mm10). Libraries were conﬁrmed to be stranded
according to RSeQC after sampling 200000 reads with MAPQ > 30. Gene counts
were generated with STAR --quant_mode (uniquely mapped, properly paired reads
that overlap the exon boundaries of each gene) using the Ensembl GTF annotation
(vM13).
For differential expression analysis, genes were ﬁltered to include those with
CPM > 1 in at least two samples. Raw count data were normalized with the TMM
method and transformed to log2-CPM. A linear model was ﬁt to the normalized
data, adjusting for batch effects, and empirical Bayes statistics were computed.
Differentially expressed genes for each KO vs. WT were identiﬁed from the linear
ﬁt after adjusting for multiple testing and ﬁltered to include those with FDR < 0.05.
Single-cell RNA ampliﬁcation. After cell lysis, RNAs were reverse transcribed into
ﬁrst cDNA strands with UP1 primer (ATATGGATCCGGCGCGCCGTC-
GACT(24)) using Super Script III (Invitrogen) at 25 °C for 5 min, and 50 °C for 30
min67. Reverse transcriptase was then inactivated by heat treatment at 70 °C for 15
min, unreacted primers were digested by ExoSAP-IT (USB), and RNA was
degraded by RNase H (Invitrogen). PolyA tail was added to the ﬁrst-strand cDNA
at its 3′ end by terminal deoxynucleotidyl transferase (Invitrogen). Second strand
cDNAs were synthesized using poly(T) primers with a C6-amine-blocked 5′ end
anchor sequence (AUP2: ATATGGATCCGGCGCGCCGTCGACT(24)). The
double-stranded cDNAs were then ampliﬁed by primers with C6-amine-blocked 5′
ends (AUP1: ATATCTCGAGGGCGCGCCGGATCCT(24) and AUP2 primers) for
20 cycles. PCR products were puriﬁed using DNA clean & Concentrator (Zymo
research). Then, 0.5–5 kb fragments were excised from agarose gels and purify by
Zymoclean gel DNA recovery kit (Zymo research). ERCC spike-in (Invitrogen)
were added in the lysis buffer (1:1,000,000) to address technical variation and
further normalization. Only cells with high quality, based on morphology and
ampliﬁcation yield of housekeeping genes and ERCC sequences, were submitted to
sequencing. Single-cell libraries were carried out according to the manufacturer’s
protocol (Nextera XT, Illumina), and sequencing was performed on an Illumina
HiSeq instrument in pair-end 100-bp reads.
RNA sequencing in U2OS cells. The total RNA from U2OS cells was extracted
with TRIzol. cDNA were generated according to the manufacturer protocols
(Illumina). In total, 50 bp single-end reads were generated using the HiSeq 2500
platform. Reads were ﬁrst mapped to the complete human rRNA sequence with
Bowtie2 (2.2.9). Unmapped reads were then mapped with STAR (2.5.2b) to the
complete human reference genome (GRCh37/hg19). Gene counts were generated
using STAR --quant_mode. Libraries were conﬁrmed to be strand-speciﬁc
according to RSeQC (2.6.4) after sampling 200000 reads with MAPQ > 30.
For differential expression analysis, genes were ﬁltered to include those with
CPM > 1 in two or more samples. Raw count data were normalized with the TMM
method and converted to log2-CPM. A linear model was ﬁt to the normalized data,
and empirical Bayes statistics were computed for each comparison. Differentially
expressed genes for each comparison were identiﬁed from the linear ﬁt after
adjusting for multiple testing and ﬁltered to include those with FDR < 0.05.
ChIP-seq. For ChIPs, cells were ﬁxed in 1% formaldehyde for 10 mn at room
temperature, quenched by adding glycine to a ﬁnal concentration of 0.125 M,
rinsed with PBS and resuspended in buffer LB1 (HEPES-KOH pH 7.5 50 mM,
NaCl 140 mM, EDTA 1mM, glycerol 10%, NP-40 0.5%, Triton X-100 0.25%+
protease inhibitors). Cells were rocked at 4 °C for 10 min, pelleted and resuspended
in buffer LB2 (NaCl 200 mM, EDTA 1mM, EGTA 0.5 mM, Tris pH 8 10mM+
protease inhibitors), pelleted again and resuspended in buffer LB3 (EDTA 1mM,
EGTA 0.5 mM, Tris pH 8 10 mM+ Protease inhibitors). Sonication was performed
on a Bioruptor (Diagenode), 0.5% N-lauroyl-sarcosine was added, and after
rocking at RT for 10 min, supernatant was kept. For the IP, chromatin (10 µg) was
incubated antibodies (around 2 µg) overnight in presence of 1% triton and 0.1%
sodium deoxycholate. Beads blocked with BSA were added the day after and
incubated at 4 °C for 3 h before processing to the washes in RIPA buffer six times
(50 mM HEPES pH 7.6, 10 mM EDTA, 0.7% DOC, 1% NP-40, 0.5 M LiCl+
protease inhibitors) and once in TEN (10 mM Tris pH 8.0, 1 mM EDTA, 50 mM
NaCl). Elution was done in TES (50 mM Tris pH 8.0, 10 mM EDTA, 1% SDS),
before reversing the cross-link overnight and incubating the samples successively
with RNAse A and proteinase K prior to phenol/chloroform/isoamyl-alcohol DNA
extraction.
CUT and RUN. For CUT and RUN, we modiﬁed slightly the published protocol68
as follows. We start from 1.106 cells of interest (here U2OS) mixed with 50.103
Drosophila S2 cells used for normalization (spike-in). Cells are washed twice with
wash buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.5 mM spermidine & Protease
inhibitors), and 10 µL of Concanavalin-A-coated bead slurry in binding buffer (20
mM HEPES pH 7.9, 10 mM KCl, 1 mM CaCl2, 1 mM MnCl2) is added and rotated
for 10 mn at RT. Tubes are put on a magnetic stand and buffer is replaced by 50 µL
antibody solution (2 mM EDTA, 1:100 antibody stock in wash buffer supplemented
with 0.1% digitonin). Beads are then rotated for 1 h at RT. After washing the beads
in wash buffer-0.1% digitonin, they are incubated for 10 mn with pA-MNase
diluted in wash buffer-0.1% digitonin. Beads are washed twice with wash buffer-
0.1% digitonin and placed in ice–water bath prior to the addition of 2 mM CaCl2
(ﬁnal concentration) for 30 mn. Digestion is stopped by addition of 2× Stop buffer
(340 mM NaCl, 20 mM EDTA, 4 mM EGTA, 0.02 % digitonin, 1:200 RNase A).
Chromatin is recovered by incubating the samples on a heat block at 37 °C for 10
mn, centrifuged, and placed on a magnetic stand. The supernatant is then puriﬁed
on nucleospin Gel and PCR clean up (Macherey Nagel).
Sequencing and alignment and peak calling. In total, 100 bp single-end reads
were generated using the HiSeq2500 sequencer for H3K27me3 ChIP-seq (WT,
dEED, and dCxorf67), and 50 bp paired-end reads for CUT&RUN samples (Suz12,
H3K27ac, H2AK119ub, H3K27me3, and IgG). Reads were simultaneously mapped
to the human (GRCh37/hg19) and drosophila (dm6) reference genomes with
Bowtie2 (2.2.9) using end-to-end alignment with the preset --very-sensitive. PCR
duplicates were removed with Picard Tools MarkDuplicates (1.97) and BAM ﬁles
were ﬁltered to exclude common artifact regions (http://mitra.stanford.edu/
kundaje/akundaje/release/blacklists/hg19-human). Peaks were called with MACS2
on combined replicates using the EED KO as a control for the K27me3 and SUZ12
ChIP and IgG control for CUT&RUN samples with the following parameters: -f
BAM --gsize hs --broad --broad-cutoff 0.1 --bdg. Reads were counted in bins of
length 50 and RPKM normalized and converted to bigWig format using DeepTools
bamCoverage (2.4.1). Spike-in normalization: reads mapping to the drosophila
genome were counted into 10 kb bins and scale factors were calculated using
DESeq2 estimateSizeFactors.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
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